Projekt

Randomized study with a run-in feasibility phase to assess the added value of Clofarabine in combination with standard remission-induction chemotherapy in patients aged 18-65 years with previously untreated acute myeloid leukemia (AML) or myelodysplasia (MDS) RAEB with IPSS (grösser gleich 1.5) A multicenter phase III trial

Automatisch geschlossen · 2010 bis 2013